Selection of linearity range in bioanalysis [Bioanalytics]

posted by cakhatri – India, 2018-05-03 12:35 (2979 d 17:39 ago) – Posting: # 18752
Views: 3,279

Dear Deepti Maru,

The need to have lower LOQ (5,7 or 10 half lives) should be correlated to the number of half lives upto which sample is collected as per protocol or likely to be collected

If the sampling is carried out upto 6 half lives - For a drug with 12 Hr Half life, the last sampling point will be 72 hours. Under such scenario, LOQ can be upto 7 half lives

This will ensure possibility of minimal BLQ samples in absorption / elimination phase.

It is necessary to have a reproducible LOQ

Regards
Chirag

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
293 visitors (0 registered, 293 guests [including 29 identified bots]).
Forum time: 06:14 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5